Financials

News Discussions Technicals Seasonals

CHOSA fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Chosa Oncology AB operates as a biotechnology company, which focuses on developing drugs related to cancer treatment. Its products include iCIP, LiPlaCis and DRP. The company was founded on January 11, 2023 and is headquartered in Lund, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

CHOSA has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company